Validation of the Rome Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbation: A Multicenter Cohort Study

References

• Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–458.
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Decramer M, Celli BR, Mueller A, Metzdorf N, Tashkin DP. Effect of a single exacerbation on decline in lung function in COPD. Respir Med. 2017;128:85–91. doi:10.1016/j.rmed.2017.04.013
   PubMed Web of Science ®Google Scholar
• Hurst JR, Skolnik N, Hansen GJ, et al. Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life. Eur J Intern Med. 2020;73:1–6. doi:10.1016/j.ejim.2019.12.014
   PubMed Web of Science ®Google Scholar
• A global strategy for prevention, diagnosis and management of COPD: 2022 report. Available from: https://goldcopd.org/2022-gold-reports-2/. Accessed January 9, 2024.
   Google Scholar
• Kim V, Aaron SD. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. Europ Resp J. 2018;52(5):1801261. doi:10.1183/13993003.01261-2018
   PubMed Web of Science ®Google Scholar
• Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med. 2009;169(17):1595–1602. doi:10.1001/archinternmed.2009.270
   PubMedGoogle Scholar
• Echevarria C, Steer J, Heslop-Marshall K, et al. Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax. 2016;71(2):133–140. doi:10.1136/thoraxjnl-2015-207775
   PubMed Web of Science ®Google Scholar
• Huang Q, He C, Xiong H, et al. DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMJ Open. 2020;10(10):e037923. doi:10.1136/bmjopen-2020-037923
   PubMed Web of Science ®Google Scholar
• Hawthorne G, Richardson M, Greening NJ, et al. A proof of concept for continuous, non-invasive, free-living vital signs monitoring to predict readmission following an acute exacerbation of COPD: a prospective cohort study. Respir Res. 2022;23(1):102. doi:10.1186/s12931-022-02018-5
   PubMed Web of Science ®Google Scholar
• Celli BR, Fabbri LM, Aaron SD, et al. An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: the Rome proposal. Am J Respir Crit Care Med. 2021;204(11):1251–1258. doi:10.1164/rccm.202108-1819PP
   PubMed Web of Science ®Google Scholar
• Amado Diago CA, Figueira Goncalves JM, Golpe R, Esteban C, Garcia Talavera I, Garcia-Martin S. Classification of the severity of COPD exacerbations in hospitalized patients according to Rome vs GesEPOC criteria. Arch Bronconeumol. 2023;59(1):57–58. doi:10.1016/j.arbres.2022.06.009
   PubMed Web of Science ®Google Scholar
• Reumkens C, Endres A, Simons SO, Savelkoul PHM, Sprooten RTM, Franssen FME. Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients. ERJ Open Res. 2023;9(3):00569–2022. doi:10.1183/23120541.00569-2022
   PubMedGoogle Scholar
• Lee HJ, Lee JK, Park TY, Heo EY, Kim DK, Lee HW. Validation of the Rome proposal for severity of acute exacerbation of chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2023;17:17534666231172917. doi:10.1177/17534666231172917
   Web of Science ®Google Scholar
• Gift AG, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care. 1998;7:200–204. doi:10.4037/ajcc1998.7.3.200
   PubMedGoogle Scholar
• Noell G, Cosio BG, Faner R, et al. Multi-level differential network analysis of COPD exacerbations. Europ Resp J. 2017;50(3):1700075. doi:10.1183/13993003.00075-2017
   PubMed Web of Science ®Google Scholar
• Burton C, Pinnock H, McKinstry B. Changes in telemonitored physiological variables and symptoms prior to exacerbations of chronic obstructive pulmonary disease. J Telemed Telecare. 2015;21(1):29–36. doi:10.1177/1357633X14562733
   PubMed Web of Science ®Google Scholar
• Borel JC, Pelletier J, Taleux N, et al. Parameters recorded by software of non-invasive ventilators predict COPD exacerbation: a proof-of-concept study. Thorax. 2015;70(3):284–285. doi:10.1136/thoraxjnl-2014-206569
   PubMed Web of Science ®Google Scholar
• Flattet Y, Garin N, Serratrice J, Perrier A, Stirnemann J, Carballo S. Determining prognosis in acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:467–475. doi:10.2147/COPD.S122382
   PubMed Web of Science ®Google Scholar
• Jensen MT, Marott JL, Lange P, et al. Resting heart rate is a predictor of mortality in COPD. Europ Resp J. 2013;42(2):341–349. doi:10.1183/09031936.00072212
   PubMed Web of Science ®Google Scholar
• Fermont JM, Masconi KL, Jensen MT, et al. Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis. Thorax. 2019;74(5):439–446. doi:10.1136/thoraxjnl-2018-211855
   PubMed Web of Science ®Google Scholar
• Elvekjaer M, Aasvang EK, Olsen RM, et al. Physiological abnormalities in patients admitted with acute exacerbation of COPD: an observational study with continuous monitoring. J Clin Monit Comput. 2020;34(5):1051–1060. doi:10.1007/s10877-019-00415-8
   PubMed Web of Science ®Google Scholar
• Smith HS, Criner AJ, Fehrle D, Grabianowski CL, Jacobs MR, Criner GJ. Use of a SmartPhone/tablet-based bidirectional telemedicine disease management program facilitates early detection and treatment of COPD exacerbation symptoms. Telemed J E Health. 2016;22(5):395–399. doi:10.1089/tmj.2015.0135
   PubMed Web of Science ®Google Scholar
• Al Rajeh AM, Aldabayan YS, Aldhahir A, et al. Once daily versus overnight and symptom versus physiological monitoring to detect exacerbations of chronic obstructive pulmonary disease: pilot randomized controlled trial. JMIR mHealth uHealth. 2020;8(11):e17597. doi:10.2196/17597
   PubMed Web of Science ®Google Scholar
• Hurst JR, Donaldson GC, Perera WR, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174(8):867–874. doi:10.1164/rccm.200604-506OC
   PubMed Web of Science ®Google Scholar
• Prins HJ, Duijkers R, van der Valk P, et al. CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions. Europ Resp J. 2019;53(5). doi:10.1183/13993003.02014-2018
   PubMed Web of Science ®Google Scholar
• Dev D, Wallace E, Sankaran R, et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med. 1998;92(4):664–667. doi:10.1016/S0954-6111(98)90515-7
   PubMed Web of Science ®Google Scholar
• Hurst JR, Donaldson GC, Quint JK, et al. Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease prospective pilot study. BMC Pulm Med. 2010;10(1):1. doi:10.1186/1471-2466-10-52
   PubMedGoogle Scholar
• Bruno CM, Valenti M. Acid-base disorders in patients with chronic obstructive pulmonary disease: a pathophysiological review. J Biomed Biotechnol. 2012;2012:915150. doi:10.1155/2012/915150
   PubMedGoogle Scholar
• Ucgun I, Oztuna F, Dagli CE, Yildirim H, Bal C. Relationship of metabolic alkalosis, azotemia and morbidity in patients with chronic obstructive pulmonary disease and hypercapnia. Respiration. 2008;76(3):270–274. doi:10.1159/000131707
   PubMed Web of Science ®Google Scholar
• Agusti A, Calverley PM, Celli B, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122. doi:10.1186/1465-9921-11-122
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S, Gyselinck I, Bafadhel M, Janssens W. Chronic obstructive pulmonary disease exacerbations: do all roads lead to Rome? Am J Respir Crit Care Med. 2022;205(9):1125–1126. doi:10.1164/rccm.202112-2717LE
   PubMed Web of Science ®Google Scholar
• Zhang J, Qin Y, Zhou C, et al. Elevated BUN upon admission as a predictor of in-hospital mortality among patients with acute exacerbation of COPD: a Secondary Analysis of Multicenter Cohort Study. Int J Chron Obstruct Pulmon Dis. 2023;18:1445–1455. doi:10.2147/COPD.S412106
   PubMed Web of Science ®Google Scholar
• Steer J, Norman EM, Afolabi OA, Gibson GJ, Bourke SC. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax. 2012;67(2):117–121. doi:10.1136/thoraxjnl-2011-200332
   PubMed Web of Science ®Google Scholar
• Steer J, Gibson J, Bourke SC. The DECAF score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–976. doi:10.1136/thoraxjnl-2012-202103
   PubMed Web of Science ®Google Scholar